glp 1 economist A second helping of weight-loss drugs is coming Soumaya Keynes and @claerb discuss
Description
For a $50 copay, Medicares new GLP-1 Bridge puts a medicine I used to prescribe knowing the coverage would never follow within reach.
Discover what current FDA data and clinical trials reveal about GLP-1 medications like Ozempic, Wegovy, and Mounjaro and cancer safety concerns.
Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety
Shop music, movies, toys & games, too
PlexusDx delivers compounded semaglutide injections starting at $149 per month to all 50 states without membership fees, making precision therapy accessible to more patients seeking sustainable weight management
